Plexus (NASDAQ:PLXS) Issues Q4 2021 Earnings Guidance

Plexus (NASDAQ:PLXS) issued an update on its fourth quarter 2021 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.130-$1.290 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.270. The company issued revenue guidance of $875 million-$915 million, compared to the consensus revenue estimate of $903.24 million.Plexus also updated its Q4 guidance to $1.13-1.29 EPS.

PLXS stock traded down $1.96 during trading on Thursday, reaching $85.62. 515 shares of the stock were exchanged, compared to its average volume of 99,315. The company has a quick ratio of 1.04, a current ratio of 1.88 and a debt-to-equity ratio of 0.19. The stock has a 50 day simple moving average of $92.79. Plexus has a 1 year low of $64.35 and a 1 year high of $101.17. The stock has a market cap of $2.45 billion, a price-to-earnings ratio of 17.14 and a beta of 1.20.

Plexus (NASDAQ:PLXS) last issued its earnings results on Tuesday, July 20th. The technology company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.22. Plexus had a net margin of 4.35% and a return on equity of 15.55%. The company had revenue of $814.39 million for the quarter, compared to the consensus estimate of $797.24 million. During the same period in the previous year, the firm earned $1.20 earnings per share. Plexus’s quarterly revenue was down 5.0% compared to the same quarter last year. Sell-side analysts expect that Plexus will post 4.58 EPS for the current fiscal year.

A number of brokerages have weighed in on PLXS. Loop Capital lifted their price target on shares of Plexus from $100.00 to $105.00 and gave the company a buy rating in a research report on Friday, June 11th. Sidoti upgraded shares of Plexus from a neutral rating to a buy rating and set a $110.00 price target for the company in a research report on Tuesday, June 22nd. Needham & Company LLC lifted their price objective on shares of Plexus from $102.00 to $110.00 and gave the company a buy rating in a report on Tuesday, May 25th. Zacks Investment Research upgraded shares of Plexus from a hold rating to a buy rating and set a $98.00 price objective for the company in a report on Monday, April 26th. Finally, Raymond James set a $85.73 price objective on shares of Plexus and gave the company a hold rating in a report on Monday. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $95.25.

In related news, VP Ronnie Darroch sold 1,000 shares of the stock in a transaction dated Monday, April 26th. The shares were sold at an average price of $94.17, for a total value of $94,170.00. Following the sale, the vice president now directly owns 5,591 shares of the company’s stock, valued at approximately $526,504.47. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 2,076 shares of the stock in a transaction dated Wednesday, April 28th. The shares were sold at an average price of $93.23, for a total transaction of $193,545.48. Following the completion of the sale, the chief accounting officer now directly owns 25,961 shares in the company, valued at $2,420,344.03. The disclosure for this sale can be found here. Insiders sold a total of 11,076 shares of company stock worth $1,045,755 over the last three months. 2.38% of the stock is currently owned by corporate insiders.

Plexus Company Profile

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also: What is the balance sheet?

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.